We are live on ! Find out more
BNTX icon

BioNTech

337 hedge funds and large institutions have $10B invested in BioNTech in 2021 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 94 increasing their positions, 103 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

159% more first-time investments, than exits

New positions opened: 88 | Existing positions closed: 34

35% more capital inflows, than outflows

Capital inflows: $2.59B | Capital outflows: $1.92B

18% more funds holding

Funds holding: 285 → 337 (+52)

0.71% more ownership

Funds ownership: 14.4% → 15.12% (+0.71%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

9% less repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 103

38% less call options, than puts

Call options by funds: $1.48B | Put options by funds: $2.37B

Holders
337
Holders Change
+52
Holders Change %
+18.25%
% of All Funds
5.88%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
88
Increased
94
Reduced
103
Closed
34
Calls
$1.48​B
Puts
$2.37​B
Net Calls
-⁠$898​M
Net Calls Change
-⁠$529​M

BNTX Hedge Fund Activity: Q3 2021 in Review

337 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2021, worth a combined $10B — up 28% from $7.84B a quarter earlier.

Buyers outnumbered sellers: 88 funds opened new BNTX positions and 34 closed out — a net gain of 54 holders — while 94 added to existing stakes and 103 trimmed.

The largest buyer was Jennison Associates, adding an estimated $1.21B. The largest seller was Gates Foundation, cutting an estimated $283M.

  • 337 institutional investors held BioNTech (BNTX) as of Q3 2021, up from 285 in Q2 2021.
  • Funds reported $10B of BioNTech stock for Q3 2021, up 28% quarter-over-quarter.
  • 88 funds opened new BioNTech positions in Q3 2021 and 34 closed out, a net change of +54 holders.
  • The largest BioNTech buyer in Q3 2021 was Jennison Associates, an estimated $1.21B added.
  • The largest BioNTech seller in Q3 2021 was Gates Foundation, an estimated $283M sold.

Based on aggregated 13F filings for Q3 2021.